Get App
Download App Scanner
Scan to Download
Advertisement

Dr. Agarwal's Shares May Rally 35% on Strong Surgical Growth, Says Motilal Oswal — Check Target Price

Dr. Agarwal's expanded its footprint to 288 facilities across geographies in FY26 and is targeting the addition of around 60 new facilities in FY27, which is expected to further boost volumes and market share.

Dr. Agarwal's Shares May Rally 35% on Strong Surgical Growth, Says Motilal Oswal — Check Target Price
Motilal Oswal remains bullish on Dr. Agarwal's structural growth story, backed by its leadership in the eye-care segment and a rapidly scaling surgical franchise.
(Photo: NDTV Profit/ AI generated image)
STOCKS IN THIS STORY
Dr Agarwals Health Care Ltd
--
Dr Agarwals Eye Hospital Ltd.
--

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

Shares of Dr Agarwal's Health Care Ltd. are likely to remain in focus after Motilal Oswal reiterated its ‘Buy' rating on the stock,  driven by strong growth momentum and continued network expansion.
The brokerage has set a target price of Rs 610 against the current market price of Rs 452, implying a potential upside of about 35%.

Motilal Oswal remains bullish on the company's structural growth story, backed by its leadership in the eye-care segment and a rapidly scaling surgical franchise. The brokerage highlighted that the company conducted around 323,000 surgeries in FY26, marking a 14.5% Yoy increase, while realisations rose nearly 8.5% due to premiumisation and a richer case mix.

A key growth driver is the company's aggressive network expansion. Dr Agarwal's Health Care expanded its footprint to 288 facilities across geographies in FY26 and is targeting the addition of around 60 new facilities in FY27, which is expected to further boost volumes and market share.

The brokerage also noted that the company's execution remains strong, supported by robust patient growth and improving operating metrics. Patient volumes rose 24% YoY to nearly 3 million in FY26, while same-store sales growth stood at 14%, reflecting healthy demand and pricing power. 

Financially, Motilal Oswal expects a strong earnings trajectory ahead, estimating a revenue, Ebitda, and PAT CAGR of 22%, 23%, and 40% respectively over FY26–FY28, aided by operating leverage, network ramp-up, and premiumisation.

Click on the attachment to read the full report:

Motilal Oswal Dr Agarwals Healthcare Update.pdf
VIEW DOCUMENT

ALSO READ: JSW Infra: Motilal Oswal Bullish on Structural Growth, Maintains Buy — Check Upside

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

To continue reading this story
You must be an existing Premium User

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Loading PDF...
Listen to the latest songs, only on JioSaavn.com